More Groups Back AMP's LDT Plan As Senate Staffers Urge Stakeholders To Press For Action

October 20, 2015 at 2:28 PM
A major medical university and a patient group for a common cardiac disease are two of the recent groups to come out in support of the Association for Molecular Pathology's CLIA-heavy legislative proposal for regulation of laboratory developed tests, according to letters sent to the Senate health committee obtained by Inside Health Policy . This comes as Senate Republican staffers recently visited with key stakeholder organizations and urged them to send letters of support for legislative action, as FDA continues...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.